Your browser doesn't support javascript.
loading
Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
Makrakis, Dimitrios; Bakaloudi, Dimitra Rafailia; Talukder, Rafee; Lin, Genevieve Ihsiu; Diamantopoulos, Leonidas N; Jindal, Tanya; Vather-Wu, Naomi; Zakharia, Yousef; Tripathi, Nishita; Agarwal, Neeraj; Dawsey, Scott; Gupta, Shilpa; Lu, Eric; Drakaki, Alexandra; Liu, Sandy; Zakopoulou, Roubini; Bamias, Aristotelis; Fulgenzi, Claudia-Maria; Cortellini, Alessio; Pinato, David; Barata, Pedro; Grivas, Petros; Khaki, Ali Raza; Koshkin, Vadim S.
Afiliación
  • Makrakis D; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA.
  • Bakaloudi DR; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA.
  • Talukder R; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA.
  • Lin GI; Department of Epidemiology, University of Washington, Seattle, WA.
  • Diamantopoulos LN; Department of Medicine, University of Pittsburgh, Pittsburgh, PA.
  • Jindal T; Helen Diller Family Cancer Center, University of California, San Francisco, San Francisco, CA.
  • Vather-Wu N; Department of Medicine, University of Iowa, Iowa City, IA.
  • Zakharia Y; Division of Oncology, Department of Medicine, University of Iowa, Iowa City, IA.
  • Tripathi N; Division of Oncology, Department of Medicine, University of Utah, Salt Lake City, UT.
  • Agarwal N; Division of Oncology, Department of Medicine, University of Utah, Salt Lake City, UT.
  • Dawsey S; Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.
  • Gupta S; Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.
  • Lu E; Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA.
  • Drakaki A; Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA.
  • Liu S; Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA.
  • Zakopoulou R; 2nd Propaedeutic Department of Internal Medicine, ATTIKON University Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Bamias A; 2nd Propaedeutic Department of Internal Medicine, ATTIKON University Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Fulgenzi CM; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, London; Department of Medical Oncology, University Campus Bio-Medico of Rome, Italy.
  • Cortellini A; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, London; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.
  • Pinato D; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, London; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
  • Barata P; Tulane Medical School, New Orleans, LA; University Hospitals Seidman Cancer Center, Cleveland, OH.
  • Grivas P; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Khaki AR; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA.
  • Koshkin VS; Division of Hematology/Oncology, Department of Medicine, Helen Diller Family Cancer Center, University of California San Francisco, San Francisco, CA. Electronic address: Vadim.koshkin@ucsf.edu.
Clin Genitourin Cancer ; 21(2): 286-294, 2023 04.
Article en En | MEDLINE | ID: mdl-36481176

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Clin Genitourin Cancer Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Clin Genitourin Cancer Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2023 Tipo del documento: Article